Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

| More on:
Six smiling health workers pose for a selfie.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sigma Healthcare Ltd (ASX: SIG) shares have been on a tear this past year.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock – which owns chemists including Amcal, Discount Drug Stores, and Guardian Pharmacy – really took off a bit over a year ago, in December 2023.

That's when Sigma first announced its $30 billion merger intentions with privately owned Chemist Warehouse.

As those merger plans progressed throughout 2024 and into 2025, Sigma shares made some ASX investors very happy.

How happy?

Let's have a look.

What $5,000 invested in Sigma shares last December is worth today

If you had a working time machine, you could pop back to 1 December 2023 and snap up Sigma shares for 69 cents apiece.

This means your $5,000 investment would have netted you 7,246 shares (ignoring brokerage fees).

In late afternoon trade today, those same shares are changing hands for $2.75 apiece.

That means the Sigma shares you bought on 1 December 2023 for $5,000, less than 15 months ago mind you, is now worth a whopping $19,926.50. Or a gain of 298.6%.

But we're not quite done with the maths yet.

Adding a little icing to this highly profitable cake, you'd also have received a total of 1 cent per share in partly franked dividends over this period.

Which would bring your total returns on the initial $5,000 investment to $19,998.96.

Now, when you're done with the time machine, can you please drop it by my office!

What's the latest on the pending merger with Chemist Warehouse?

On 30 January, ASX 200 investors learned that, as expected, Sigma shareholders had voted to approve the merger with Chemist Warehouse, with 99.86% voting 'yes'.

Sigma shareholders also agreed to elect four Chemist Warehouse executives to the Sigma board.

The Chemist Warehouse board's vote to approve the merger received 99.23% support.

Commenting on the merger on the day, Sigma chair Michael Sammells said:

Sigma has world-class distribution infrastructure and capability that is delivering best in class service to pharmacies across Australia every day.

Chemist Warehouse has unparalleled pharmacy franchise and marketing know-how and expertise which will also help elevate our support for our Amcal and Discount Drug Store franchisees.

Given the nature and value accretion of the proposed transaction, Sigma Directors unanimously recommend that shareholders vote in favour of the resolutions.

Sigma shares had been in a trading halt the day before and closed down 3.6% following the news.

Though, as we saw above, that hardly crimped the returns investors have reaped since the merger news first broke in December 2023.

The merger process was finalised this afternoon when Sigma announced that its 100% acquisition of issued shares in Chemist Warehouse via a scheme of arrangement was implemented today.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Which small cap ASX share is jumping 10% on strong results

Investors have been bidding this stock higher today. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why Macquarie forecasts 30-50% upside for these ASX All Ords healthcare stocks

Macquarie updated its target price on these three ASX All Ords healthcare stocks.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 10% on big news

This stock is catching the eye with a strong gain on Thursday. But why?

Read more »

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Healthcare Shares

Guess which popular ASX 200 stock is up nearly 60% in less than 2 months?

Investors who bought this ASX 200 stock in the recent dip have been strongly rewarded.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Are Sigma Healthcare shares a good buy now after the merger with Chemist Warehouse?

Sigma Healthcare shares have soared 154% in 12 months. Can this stellar run continue?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »